{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T10:49:32Z","timestamp":1791456572805,"version":"4.3.4"},"reference-count":4,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/cid\/ciag527","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:39:14Z","timestamp":1788521954000},"source":"Crossref","is-referenced-by-count":0,"title":["Urinary Antigen Testing for Invasive Aspergillosis: Promise and Remaining Questions"],"prefix":"10.1093","author":[{"given":"Zoe Freeman","family":"Weiss","sequence":"first","affiliation":[{"name":"Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center , Boston, Massachusetts ,","place":["USA"]},{"name":"Department of Pathology and Laboratory Medicine, Tufts Medical Center , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica S","family":"Little","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School , Boston, Massachusetts ,","place":["USA"]},{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"2026100805525876200_ciag527-B1","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2026100805525876200_ciag527-B2","author":"US Food and Drug Administration"},{"key":"2026100805525876200_ciag527-B3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1056\/NEJMc1210430","article-title":"False positive galactomannan test after ice-pop ingestion","volume":"369","author":"Guigue","year":"2013","journal-title":"N Engl J Med"},{"key":"2026100805525876200_ciag527-B4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/cid\/ciae203","article-title":"Breakthrough invasive fungal infections in patients with high-risk hematological disorders receiving voriconazole and posaconazole prophylaxis: a systematic review","volume":"79","author":"Boutin","year":"2024","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciag527\/71708989\/ciag527.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciag527\/71708989\/ciag527.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:53:02Z","timestamp":1791453182000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/advance-article\/doi\/10.1093\/cid\/ciag527\/8883140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":4,"URL":"https:\/\/doi.org\/10.1093\/cid\/ciag527","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"article-number":"ciag527"}}